Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antipsychotic medications and extreme weight gain in two health systems.

Obesity research & clinical practice - 1 Jan 2000

Arterburn David, Wood G Craig, Theis Mary Kay, Westbrook Emily O, Anau Jane, Rukstalis Margaret, Boscarino Joseph A, Daar Zahra, Gerhard Glenn S

Abstract excerpt

OBJECTIVE: We conducted this study to investigate the rate of clinically important, extreme weight gain (EWG; ≥7% body weight gain) among all second generation antipsychotic (SGA) users in two large health care systems in the United States. STUDY DESIGN: Retrospective observational cohort study. METHODS: We used electronic medical record databases of two health systems to identify adults aged 18-79 years who from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Delivery of Health Care

Share to Mental Disorders

Share to Olanzapine

Share to Piperazines

Share to Thiazoles

Share to Weight Gain

Source

Identifiers

PMID: 26361961
DOI: 10.1016/j.orcp.2015.08.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antipsychotic medications and extreme weight gain in two health systems.PMID 26361961Read ↗

Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort StudySemantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Semantic proximity Read ↗

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gainSemantic proximity Read ↗

A meta-analysis of potential genetic factors associated with antipsychotic-induced weight gain in adults with severe mental illness.Semantic proximity Read ↗

Weight gain with antipsychotic drugs: the role of the 5-HT2C receptor (HTR2C) and other genes.Semantic proximity Read ↗

Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.Semantic proximity Read ↗

Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Semantic proximity Read ↗

Does Sex affect Antipsychotic Associated Weight Gain in Patients Being Treated for Psychotic Disorders: A Protocol for a Systematic ReviewSemantic proximity Read ↗

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment.Semantic proximity Read ↗

Long-Term Effects of Early Adolescent Second-Generation Antipsychotic Exposure on Body Weight, Caloric Intake, and Metabolism-Associated Gene ExpressionSemantic proximity Read ↗

Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain.Semantic proximity Read ↗

Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.